Data Request From – Sibo Tian

Sibo Tian

2022-04-25

Disease

PCG registry

Abatary Discription

To evaluate clinical outcomes of patients with thymic malignancies treated with proton therapy (last reviewed through early 2017, now with dosimetric/DVH data) specifically looking at disease/survival endpoints, toxicity, patterns of failure, and dosimetry correlates